Cargando…

Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer

BACKGROUND: Ovarian cancer (OC) is the leading cause of gynecological cancer death and the fifth most common cause of cancer-related death in women in America. Programmed cell death played a vital role in tumor progression and immunotherapy response in cancer. METHODS: The prognostic cell death sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Le, Chen, Xi, Song, Lei, Zou, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586435/ https://www.ncbi.nlm.nih.gov/pubmed/37868825 http://dx.doi.org/10.1155/2023/7365503

Ejemplares similares

A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learning
por: Zhao, Bo, et al.
Publicado: (2023)

Machine learning developed a PI3K/Akt pathway-related signature for predicting prognosis and drug sensitivity in ovarian cancer
por: Han, Xiaofang, et al.
Publicado: (2023)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma
por: Ding, Dongxiao, et al.
Publicado: (2023)

Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response
por: Lian, Xin, et al.
Publicado: (2023)

Construction of an Immunophenoscore-Related Signature for Evaluating Prognosis and Immunotherapy Sensitivity in Ovarian Cancer
por: Jiang, Haonan, et al.
Publicado: (2023)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

Platelet RNA signature independently predicts ovarian cancer prognosis by deep learning neural network model
por: Liu, Chun-Jie, et al.
Publicado: (2022)

Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
por: Dong, Li, et al.
Publicado: (2023)

The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma
por: Hu, Lin, et al.
Publicado: (2022)

Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumors
por: Cotler, Max J., et al.
Publicado: (2022)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Machine learning-based predictive models and drug prediction for schizophrenia in multiple programmed cell death patterns
por: Feng, Yu, et al.
Publicado: (2023)

Impacts of ovarian preservation on the prognosis of neuroendocrine cervical carcinoma: a retrospective analysis based on machine learning
por: Xiang, Xuesong, et al.
Publicado: (2023)

Identification of an energy metabolism-related gene signature in ovarian cancer prognosis
por: Wang, Lei, et al.
Publicado: (2020)

Identification of 5-methylcytosine-related signature for predicting prognosis in ovarian cancer
por: Wang, Lei, et al.
Publicado: (2021)

Metal-dependent programmed cell death-related lncRNA prognostic signatures and natural drug sensitivity prediction for gastric cancer
por: Song, Xuesong, et al.
Publicado: (2022)

A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2023)

m5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning
por: Huang, Maoxin, et al.
Publicado: (2021)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning
por: Wang, Qilong, et al.
Publicado: (2023)

A necroptosis‐related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma
por: Chen, Junliang, et al.
Publicado: (2022)

The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome
por: Walker, Thomas D. J., et al.
Publicado: (2023)

Novel gene signatures for prognosis prediction in ovarian cancer
por: Bao, Mingyang, et al.
Publicado: (2020)

Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes
por: Xu, Chengbo, et al.
Publicado: (2023)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
por: Qi, Xiangjun, et al.
Publicado: (2022)

Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
por: Liu, Da, et al.
Publicado: (2023)

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma
por: Zhang, Jianxiang, et al.
Publicado: (2023)

An Environment-Sensitive Synthetic Microbial Ecosystem
por: Hu, Bo, et al.
Publicado: (2010)

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
por: Zhao, Yi, et al.
Publicado: (2023)

Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortality
por: Zhang, Xinyu, et al.
Publicado: (2018)

Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning
por: Xiao, Yingqi, et al.
Publicado: (2022)

Machine learning-based prediction of survival prognosis in cervical cancer
por: Ding, Dongyan, et al.
Publicado: (2021)

Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients
por: Pawłowska, Anna, et al.
Publicado: (2020)

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Li, et al.
Publicado: (2022)

Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients
por: Zhang, Guang-Zhi, et al.
Publicado: (2021)

Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma
por: Li, Li, et al.
Publicado: (2023)

Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
por: Wang, Jiao, et al.
Publicado: (2023)

Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients
por: Chi, Hao, et al.
Publicado: (2022)

A miRNA signature assessing ovarian cancer prognosis
por: Bagnoli, Marina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bd82p3lgcm15sf5dgeca737enr